Seven Eight Capital’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Seven Eight Capital’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1	Closed	–	–	767
2015 Q1	$0	Buy	+1	New	+$147	﹤0.01%	749
2014 Q4	–	Sell	-3,100	Closed	-$484K	–	765
2014 Q3	$484K	Buy	3,100 +1,300	+72%	+$188K	0.37%	80
2014 Q2	$222K	Buy	+1,800	New	+$199K	0.21%	154
2014 Q1	–	Sell	-900	Closed	-$81K	–	635
2013 Q4	$81K	Buy	+900	New	+$71.8K	0.09%	314

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Seven Eight Capital's SLXP Position: Q2 2015 in Review

Seven Eight Capital sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1 share.

Seven Eight Capital first reported a position in SLXP in Q4 2013 and held it in 4 quarters. The position peaked at $484K in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Seven Eight Capital reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Seven Eight Capital sold 1 SALIX PHARMACEUTICALS LTD DEL share in Q2 2015.
Seven Eight Capital first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2013 and held it in 4 quarters.
Seven Eight Capital's SALIX PHARMACEUTICALS LTD DEL position peaked at $484K in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Seven Eight Capital's 13F filing for Q2 2015, filed 14 Aug 2015.